Drugs / CAR.B7-H3T cells
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT05366179 | Sep 2022 → May 2030 expected | glioblastoma | UNC Lineberger Comprehensive Cancer Center | Recruiting | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | CAR.B7-H3T cells | ClinicalTrials.gov intervention name — accepted as the source's own label NCT05366179 ↗ |
| Modality | Cell therapy | “chimeric antigen receptor T cells (CAR-T) cells targeting the B7-H3 antigen” NCT05366179 ↗ |